Macular hole formation following intravitreal injection of ranibizumab for branch retinal vein occlusion: A case report

被引：7
作者：
Muramatsu D. [1 ]
Mitsuhashi R. [1 ]
Iwasaki T. [1 ]
Goto H. [2 ]
Miura M. [1 ]
机构：
[1] Tokyo Medical University, Ibaraki Medical Center, 3-20-1 Chuo, Ami-machi, Inashiki-gun, 300-0395, Ibaraki
[2] Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, 160-0023, Tokyo
来源：
BMC Research Notes | / 8卷 / 1期
关键词：
Branch retinal vein occlusion; Complication; Macular edema; Macular hole; Ranibizumab;
D O I：
10.1186/s13104-015-1324-4
中图分类号：
学科分类号：
摘要：
Background: Macular hole formation after anti-vascular endothelial growth factor therapy is a rare complication. We report macular hole formation after intravitreal ranibizumab injection for branch retinal vein occlusion. Case presentation: A 63-year-old Asian male was treated with intravitreal ranibizumab injection for chronic macular edema with branch retinal vein occlusion in his right eye. Before treatment, best-corrected visual acuity in his right eye was 20/200. Nine days after injection, a full thickness macular hole developed with reduction of macular edema. After pars plana vitrectomy combined with cataract surgery, the macular hole was successfully closed, and the best-corrected visual acuity in his right eye improved to 20/40. Conclusion: The possibility of an infrequent complication like macular hole should be considered for intravitreal ranibizumab for macular edema with branch retinal vein occlusion. © 2015 Muramatsu et al.
引用
收藏
相关论文
共 15 条
  • [1] Argon laser photocoagulation for macular edema in branch vein occlusion, Am J Ophthalmol, 98, pp. 271-282, (1984)
  • [2] Scott I.U., Ip M.S., Vanveldhuisen P.C., Oden N.L., Blodi B.A., Fisher M., Chan C.K., Gonzalez V.H., Singerman L.J., Tolentino M., A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6, Arch Ophthalmol, 127, pp. 1115-1128, (2009)
  • [3] Okunuki Y., Usui Y., Katai N., Kezuka T., Takeuchi M., Goto H., Wakabayashi Y., Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion, Am J Ophthalmol, 151, pp. 610-616, (2011)
  • [4] Campochiaro P.A., Heier J.S., Feiner L., Gray S., Saroj N., Rundle A.C., Murahashi W.Y., Rubio R.G., Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study, Ophthalmology, 117, pp. 1102-1112, (2010)
  • [5] Ogura Y., Roider J., Korobelnik J.F., Holz F.G., Simader C., Schmidt-Erfurth U., Vitti R., Berliner A.J., Hiemeyer F., Stemper B., Zeitz O., Sandbrink R., Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study, Am J Ophthalmol, 158, pp. 1032-1038, (2014)
  • [6] Rosenfeld P.J., Fung A.E., Puliafito C.A., Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central vein occlusion, Ophthalmic Surg Lasers Imaging, 36, pp. 336-339, (2005)
  • [7] Miura M., Iwasaki T., Goto H., Macular hole formation after intravitreal bevacizumab administration in a patient with myopic choroidal neovascularization, Retin Cases Brief Rep, 5, pp. 149-152, (2011)
  • [8] Moisseiev E., Goldstein M., Loewenstein A., Moisseiev J., Macular hole following intravitreal bevacizumab injection in choroidal neovascularization caused by age-related macular degeneration, Case Rep Ophthalmol, 1, pp. 36-41, (2010)
  • [9] Querques G., Souied E.H., Soubrane G., Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration, Acta Ophthalmol, 87, pp. 235-237, (2009)
  • [10] Grigoropoulos V., Emfietzoglou J., Nikolaidis P., Theodossiadis G., Theodossiadis P., Full-thickness macular hole after intravitreal injection of ranibizumab in a patient with retinal pigment epithelium detachment and tear, Eur J Ophthalmol, 20, pp. 469-472, (2010)
12